- Home
- Article
- Hospitals & Clinics
- Specialty Clinics
- Zeon Lifesciences Disrupts Probiotic Manufacturing With Intelicaps Technology
Zeon Lifesciences—a manufacturer of nutraceutical and herbal products on Tuesday announced that it has redefined the way probiotics are manufactured ensuring improved viability and effectiveness.
In its press release the company stated, “Zeon Lifesciences is delighted to announce a significant breakthrough in the manufacturing process of probiotics, utilizing the latest Intelicaps technology.”
“Zeon has redefined the way probiotics are manufactured, ensuring improved viability and effectiveness. Probiotics have long been acknowledged for their health benefits and utilizing the latest Intelicaps technology, Zeon Lifesciences has overcome major hurdles in its manufacturing process by encapsulating live bacteria in a protective casing. This exceptional technique ensures the survival and delivery of probiotics to their intended destination within the body, boosting their efficacy,” it added.
Intelicaps have been integrated into Zeon's manufacturing process, establishing a new industry standard in probiotic manufacturing. The technology also works as a shield against external factors such as heat, moisture, and acidity, which can compromise the integrity of live bacteria.
As a result, Zeon's probiotic formulations retain their potency and remain viable until consumed, offering numerous benefits to consumers.
This significant achievement sets Zeon Lifesciences apart as the one-of-a-kind player in the industry to harness the immense potential of Intelicaps, positioning it at the vanguard of probiotic manufacturing. By leveraging this ground-breaking technology, Zeon Lifesciences has also secured its position as the undisputed pioneer in technology advancement, surpassing all competitors and establishing an outstanding benchmark in the field.
“We are elated to unveil our revolutionary accomplishments in probiotic manufacturing, framing new standards for effectiveness. With the integration of Intelicaps technology, we have mitigated the obstacles that hindered the potential of probiotics, ensuring their optimal impact on health. Furthermore, it gives us immense pleasure to announce that Zeon Lifesciences is the solitary player in the industry that has embraced and effectively employed this one-of-a-kind technological marvel that will disrupt the probiotic industry,” said Suresh Garg, CMD and Founder, Zeon Lifesciences Ltd.
Recently, Zeon Lifesciences announced its expansion into India's pet wellness industry with the unveiling of an industry-leading product line, dedicated to veterinary nutrition. The comprehensive product range focuses on various aspects of pet health, including general wellness, bone and joint health, as well as skin and coat health and is conveniently available in powder, spray, and liquid oral formats, offering flexibility for pet owners.